UK medical sciences would have to ‘scale back ambition’ if we became isolated from the European Union, academic says

Posted by ap507 at Jun 21, 2016 12:10 PM |
Professor Andrew Tobin from the University of Leicester discusses how remaining in the EU can help address some of the largest biomedical challenges - such as a rise in dementia and infectious diseases worldwide

Issued by University of Leicester Press Office on 21 June 2016

Professor Andrew Tobin is available to discuss UK medical science and how remaining in the EU can help to address some of the world’s largest biomedical challenges. To arrange an interview contact him on tba@le.ac.uk or call 0116 252 2935     

A photograph of Professor Andrew Tobin is available here: https://www.dropbox.com/sh/yew9prwqdpiha7c/AAD-dE76mpBTeU8XZJDtrD8Pa?dl=0

UK medical sciences may have to ‘scale back its ambition’ if Britain leaves the European Union, according to an expert from the University of Leicester.

Leaving the EU could also make it more difficult to address some of the greatest biomedical challenges, such as a global increase in dementia and infectious diseases.

In an article for Think: Leicester, the University of Leicester’s platform for academic opinion pieces, Professor Andrew Tobin from the University of Leicester Department of Molecular and Cell Biology discusses the benefits to UK medical sciences by remaining in the EU, and outlines some of the challenges the sector could face if the UK votes to leave during the referendum on Thursday 23 June.

Professor Tobin said: “There are obvious benefits to UK medical sciences of being part of the European Union not least the opportunity to bid for multi-million Euro collaborative grants through the European Research Council and a framework that allows for extensive collaboration across European laboratories. But there is much more. 

“Addressing the very largest biomedical questions facing the world today, including the startling rise in dementia and the increasing burden of infectious diseases such as malaria, requires bringing the most advanced technologies together with the world’s best minds and innovative approaches. UK universities and research institutes have led the world in promoting open collaboration where nationality holds no barriers – essentially the UK proclaims that science has no borders.

“Being an integral part of the European Union is completely consistent with this approach. By removing the restrictions otherwise placed on the movement of researchers, ideas and technologies the European Union is an ideal environment not only for the continued success of UK science but importantly puts in place the framework that allows us as to address the biggest questions in medical science.

“My laboratory would certainly be far less competitive and have to scale back our ambition if we were to become isolated from the European Union. It is not just about the funding – it is progress that comes from the culture of collaboration and co-operation that lies at the heart of my opinion that the UK biomedical community is best placed within the European Union.”

The article ‘To remain – why this is important for UK medical sciences’ is available on Think: Leicester here: https://www2.le.ac.uk/offices/press/think-leicester/politics-and-international-relations/2016-1/to-remain-2013-why-this-is-important-for-uk-medical-sciences

Notes to editors:

To arrange an interview contact Professor Andrew Tobin on tba@le.ac.uk

Share this page: